Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology Average | - - | - - | - - | 13,586.46 | 829.38 | 203.85 | -210.63 | 31.99 | 0.02 | 13.6286 | -0.41 | -107.1788 | -2,404.7789 | -9.24 | -8.70 | 793.6913 | - - | ||
Maximum | - - | - - | - - | 593,913.00 | 65,349.00 | 25,407.00 | 99,050.00 | 5,305.00 | 0.94 | 1,336.3467 | 6.70 | 300.5100 | 8,534.8500 | 38.40 | 835.37 | 6,156.2100 | - - | ||
Minimum | - - | - - | - - | 0.00 | 0.00 | -1,175.00 | -56,335.00 | -1,185.00 | 0.00 | -164.8536 | -8.99 | -10,177.5800 | -144,478.0000 | -155.91 | -1,263.79 | 0.0700 | - - | ||
Vertex Pharmaceuticals Incorporated VRTX | 478.55 | 4.39 0.92% | 77 vs. 1,141 | 123,513.00 | 2,687.00 | 1,099.00 | 1,058.00 | 11,242.00 | 4.2600 | 24.6835 | 0.00 | 87.25 | 40.92 | 5.93 | 4.60 | 315.20 | 258.00 | ||
Gilead Sciences, Inc. GILD | 83.88 | -0.02 -0.02% | 846 vs. 7,032 | 104,423.00 | 6,686.00 | -4,170.00 | 2,114.00 | 10,656.00 | -3.3400 | -5.4485 | 1.09 | 76.79 | -62.37 | -23.78 | -7.41 | 82.43 | 1,244.00 | ||
Illumina, Inc. ILMN | 134.59 | 3.62 2.76% | 122 vs. 2,392 | 21,439.00 | 1,076.00 | -126.00 | 41.00 | -145.00 | -0.7900 | -41.8700 | 0.00 | 61.99 | -11.71 | -2.20 | -1.25 | 119.74 | 159.00 | ||
Intel Corporation INTC | 21.18 | 0.41 1.97% | 16,568 vs. 73,326 | 90,565.00 | 12,724.00 | -381.00 | -7,193.00 | 68,224.00 | -0.0898 | -123.9198 | 0.28 | 41.00 | -2.99 | -0.36 | -0.20 | 91.07 | 4,276.00 |